These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19837380)

  • 1. Scleritis and systemic disease association in a community-based referral practice.
    Raiji VR; Palestine AG; Parver DL
    Am J Ophthalmol; 2009 Dec; 148(6):946-50. PubMed ID: 19837380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L; Christen W; Foster CS
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
    Wieringa WG; Wieringa JE; ten Dam-van Loon NH; Los LI
    Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients.
    McCluskey PJ; Watson PG; Lightman S; Haybittle J; Restori M; Branley M
    Ophthalmology; 1999 Dec; 106(12):2380-6. PubMed ID: 10599675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patients with scleritis for systemic disease.
    Akpek EK; Thorne JE; Qazi FA; Do DV; Jabs DA
    Ophthalmology; 2004 Mar; 111(3):501-6. PubMed ID: 15019326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases.
    Gonzalez-Gonzalez LA; Molina-Prat N; Doctor P; Tauber J; Sainz de la Maza MT; Foster CS
    Ophthalmology; 2012 Jul; 119(7):1460-4. PubMed ID: 22463821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful infliximab treatment of posterior scleritis in a 13-year-old child refractory to other immunosuppressive therapy.
    Weiss K; Rieger R; Keitzer R; Pleyer U
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1735-7. PubMed ID: 17674021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indication and effect of immunosuppression in patients with scleritis].
    Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for the treatment of refractory scleritis.
    Doctor P; Sultan A; Syed S; Christen W; Bhat P; Foster CS
    Br J Ophthalmol; 2010 May; 94(5):579-83. PubMed ID: 19955205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.
    Ragam A; Kolomeyer AM; Fang C; Xu Y; Chu DS
    Ocul Immunol Inflamm; 2014 Dec; 22(6):469-77. PubMed ID: 24354512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
    Erkanli L; Akova YA; Guney-Tefekli E; Tugal-Tutkun I
    Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleritis associated with sarcoidosis.
    Dursun D; Akova YA; Bilezikçi B
    Ocul Immunol Inflamm; 2004 Jun; 12(2):143-8. PubMed ID: 15512984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Posterior scleritis: clinical features, systemic association, treatment and evolution of 23 patients].
    Machado Dde O; Curi AL; Bessa TF; Campos WR; Oréfice F
    Arq Bras Oftalmol; 2009; 72(3):321-6. PubMed ID: 19668960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleritis: a clinicopathologic study of 55 cases.
    Riono WP; Hidayat AA; Rao NA
    Ophthalmology; 1999 Jul; 106(7):1328-33. PubMed ID: 10406616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and ocular complications of patients with scleritis in Japanese.
    Tanaka R; Kaburaki T; Ohtomo K; Takamoto M; Komae K; Numaga J; Fujino Y; Aihara M
    Jpn J Ophthalmol; 2018 Jul; 62(4):517-524. PubMed ID: 29796754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab therapy for the treatment of refractory ocular inflammatory disease.
    Sobrin L; Kim EC; Christen W; Papadaki T; Letko E; Foster CS
    Arch Ophthalmol; 2007 Jul; 125(7):895-900. PubMed ID: 17620567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.